Abstract
Purpose
The aim of the study was to assess the changes in the quality of life (QOL) of Chinese schizophrenia patients and to identify their predictors over a 1-year follow-up.
Methods
A cohort of 116 schizophrenia patients was recruited, and their socio-demographic and clinical characteristics including psychotic and depressive symptoms, drug-induced side effects, social functioning, and QOL were assessed with standardized rating instruments. The patients received standard psychiatric care and were followed up for 1 year.
Results
The psychotic and depressive symptoms, extrapyramidal side effects, and QOL domains of physical functioning, role limitations due to physical problems, social functioning, and role limitations due to emotional problems all improved significantly. Social functioning was a predictor of baseline QOL and change at 1-year follow-up.
Conclusions
Routine clinical management was effective in improving schizophrenia patients’ psychopathology and several domains of QOL. QOL was related to the level of social functioning and had only a weak association with socio-demographic factors.
Abbreviations
- QOL:
-
Quality of life
- EPS:
-
Extrapyramidal side effects
- PANSS:
-
Positive and Negative Syndrome Scale
- MADRS:
-
Montgomery-Åsberg Depression Rating Scale
- SAS:
-
Simpson-Angus Scale of Extrapyramidal Symptoms
- SDSS:
-
Social Disability Screening Schedule
- PF:
-
Physical functioning
- RP:
-
Role limitations due to physical problems
- BP:
-
Bodily pain
- GH:
-
General health
- VT:
-
Vitality
- SF:
-
Social functioning
- RE:
-
Role limitations due to emotional problems
- MH:
-
Mental health
References
Sartorius, N. (1997). Quality of life, mental disorders: A global perspective. Chichester: John Wiley.
Chan, G. W., Ungvari, G. S., Shek, D. T., & Leung Dagger, J. J. (2003). Hospital and community-based care for patients with chronic schizophrenia in Hong Kong—Quality of life and its correlates. Social Psychiatry and Psychiatric Epidemiology, 38, 196–203.
Law, C. W., Chen, E. Y., Cheung, E. F., Chan, R. C., Wong, J. G., Lam, C. L., et al. (2005). Impact of untreated psychosis on quality of life in patients with first-episode schizophrenia. Quality of Life Research, 14, 1803–1811.
Xiang, Y. T., Weng, Y. Z., Leung, C. M., Tang, W. K., & Ungvari, G. S. (2008). Socio-demographic and clinical correlates of lifetime suicide attempts and their impact on quality of life in Chinese schizophrenia patients. Journal of Psychiatric Research, 42, 495–502.
Xiang, Y. T., Weng, Y. Z., Leung, C. M., Tang, W. K., & Ungvari, G. S. (2008). Subjective quality of life in outpatients with schizophrenia in Hong Kong and Beijing: Relationship to socio-demographic and clinical factors. Quality of Life Research, 17, 27–36.
Xiang, Y. T., Weng, Y. Z., Leung, C. M., Tang, W. K., Lai, K. Y., & Ungvari, G. S. (2009). Prevalence and correlates of insomnia and its impact on quality of life in Chinese schizophrenia patients. Sleep, 32, 105–109.
He, Y. L., & Zhang, M. Y. (1997). The positive and negative syndrome scale (PANSS) and its application (in Chinese). Journal of Clinical Psychiatry, 7, 353–355.
Montgomery, S. A., & Asberg, M. (1979). A new depression scale designed to be sensitive to change. British Journal of Psychiatry, 134, 382–389.
Simpson, G. M., & Angus, J. W. (1970). A rating scale for extrapyramidal side effects. Acta Psychiatrica Scandinavica, 212(Supplementum), 11–19.
Wu, W. Y. (1998). Social Disability Screening Schedule-Chinese version. In M. Y. Zhang (Ed.), Handbook of rating scales in psychiatry (pp 163–166). Changsha: Hunan, Hunan Science and Technology Press.
Xu, J., Hu, M. Y., Yang, Y. B., Wang, B. H., & Xie, Y. N. (1999). Medical outcome study 36 item short form (SF-36) (in Chinese). Chinese Journal of Behavioral Medical Science, 8, 150–152.
Xu, D., & Xu, D. M. (2001). Investigation of marital status for 758 schizophrenics (in Chinese). Zhongyuan Mental Health, 7, 136–139.
Guo, Z. Y., Liu, J. M., Zhang, J. Z., Guo, H., & Wang, A. Q. (2008). Efficacy of quetiapine in the treatment of schizophrenic patients and its effect on quality of life (in Chinese). Chinese Journal of Health Psychology, 16, 544–546.
Potkin, S. G., Weiden, P. J., Loebel, A. D., Warrington, L. E., Watsky, E. J., & Siu, C. O. (2009). Remission in schizophrenia: 196-week, double-blind treatment with ziprasidone vs. haloperidol. International Journal of Neuropsychopharmacology, 12, 1233–1248.
Wegener, S., Redoblado-Hodge, M. A., Lucas, S., Fitzgerald, D., Harris, A., & Brennan, J. (2005). Relative contributions of psychiatric symptoms and neuropsychological functioning to quality of life in first-episode psychosis. Australian and New Zealand Journal of Psychiatry, 39, 487–492.
Browne, S., Roe, M., Lane, A., Gervin, M., Morris, M., Kinsella, A., et al. (1996). Quality of life in schizophrenia: Relationship to sociodemographic factors, symptomatology and tardive dyskinesia. Acta Psychiatrica Scandinavica, 94, 118–124.
Corrigan, P. W., & Buican, B. (1995). The construct validity of subjective quality of life for the severely mentally ill. Journal of Nervous and Mental Disease, 183, 281–285.
Xiang, Y. T., Weng, Y. Z., Leung, C. M., Tang, W. K., & Ungvari, G. S. (2007). Quality of life of Chinese schizophrenia outpatients in Hong Kong: Relationship to sociodemographic factors and symptomatology. Australian and New Zealand Journal of Psychiatry, 41, 442–449.
Kwon, J. S., & Choi, J. S. (2009). Social functioning and quality of life as measures of effectiveness in the treatment of schizophrenia. World Psychiatry, 8, 35–36.
Trompenaars, F. J., Masthoff, E. D., Van Heck, G. L., De Vries, J., & Hodiamont, P. P. (2007). Relationships between social functioning and quality of life in a population of Dutch adult psychiatric outpatients. International Journal of Social Psychiatry, 53, 36–47.
Franz, M., Meyer, T., Reber, T., & Gallhofer, B. (2000). The importance of social comparisons for high levels of subjective quality of life in chronic schizophrenic patients. Quality of Life Research, 9, 481–489.
Katschnig, H. (2000). Schizophrenia and quality of life. Acta Psychiatrica Scandinavica, 407(Suppl), 33–37.
Acknowledgments
This study was supported by Direct Grant for Research from the Chinese University of Hong Kong (No. 2041454), the National Natural Science Foundation of China (No. 30800367), the Beijing Nova Program of the Beijing Municipal Science and Technology Commission (No. 2008B59), and the 10th National 5-Year Plan Foundation of the Ministry of Science and Technology Program (No. 2004BA720A22).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Xiang, YT., Wang, CY., Wang, Y. et al. Socio-demographic and clinical determinants of quality of life in Chinese patients with schizophrenia: a prospective study. Qual Life Res 19, 317–322 (2010). https://doi.org/10.1007/s11136-010-9593-9
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11136-010-9593-9